ABSTRACT
Introduction Hemifacial spasm (HFS) is a not uncommon, debilitating movement disorder. This retrospective study examines 25 years of experience with Botulinum neurotoxin (BoNT) injections for HFS in Malaysia.
Objective To assess BoNT’s long-term effectiveness in treating HFS in a private practice.
Methods Data from 35 patients, including demographics, treatment outcomes, and complications, were collected from a private clinic over 25 years.
Results BoNT demonstrated a decreasing dose trend over time, with extended treatment intervals. Complications were rare and transient, with high patient retention.
Conclusion BoNT is a safe and effective long-term HFS treatment, enhancing accessibility in private practice, complementing public healthcare services.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of Alpha Specialist Centre waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.